Victrex (OTCMKTS:VTXPF) was downgraded by research analysts at ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Thursday.
Separately, Zacks Investment Research upgraded Victrex from a “sell” rating to a “hold” rating in a research note on Thursday, August 16th.
Shares of OTCMKTS:VTXPF opened at $34.95 on Thursday. Victrex has a 1 year low of $31.49 and a 1 year high of $45.68.
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It operates through two segments, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications.
Recommended Story: How Buying a Call Option Works
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.